Continuous Risk Monitoring and Management of Heart Failure: Rationale and Design of the ALLEVIATE-HF Trial
ALLEVIATE-HF will evaluate how ICM-based HF management can impact the outcomes of patients with HF regardless of ejection fraction.
Authors
- Brian Van Dorn (ORCID: https://orcid.org/0000-0002-8685-5442)
- Verla Laager
- Muhammad Shahzeb Khan (ORCID: https://orcid.org/0000-0002-6578-4753)
- Michael R. Zile (ORCID: https://orcid.org/0000-0001-7076-221X)
- Rami Kahwash (ORCID: https://orcid.org/0000-0001-5009-2909)
- Bart Gerritse (ORCID: https://orcid.org/0000-0002-3121-1367)
- Jennifer Wehking
- Aimee Laechelt
- Nirav Patel (ORCID: https://orcid.org/0000-0002-6176-1255)
- Shantanu Sarkar (ORCID: https://orcid.org/0000-0002-3613-5463)
- Javed Butler
Institutions
- Medical University of South Carolina (US)
- Baylor College of Medicine (US)
- Temple College (US)
- Bakken Museum (US)
- Jackson Memorial Hospital (US)
- Medtronic (Ireland) (IE)
- University of Mississippi Medical Center (US)
- Medtronic (United States) (US)
- Baylor Medical Center at Garland (US)
- Heart Hospital Baylor Plano (US)
- Plano Cancer Institute (US)
- Medtronic (Netherlands) (NL)
- Ralph H. Johnson VA Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1002/ejhf.3595
- Citations
- 5
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.94